Core Viewpoint - InnovAge Holding Corp. has announced a joint venture with Tampa General Hospital to enhance community-based care options for seniors in the Tampa Bay area, focusing on improving access to quality care for clinically frail and underserved seniors [1][2]. Company Overview - InnovAge is a leader in senior care through the Program of All-Inclusive Care for the Elderly (PACE), aiming to help seniors live independently at home while receiving necessary healthcare and support [1][5]. - As of March 31, 2025, InnovAge served approximately 7,530 participants across 20 centers in six states [6]. Joint Venture Details - The joint venture aims to expand innovative community-based care options and improve access to quality care for seniors in Hillsborough, Pasco, and Hernando counties [2]. - The InnovAge Florida PACE center in Tampa has a 35,000-square-foot facility capable of serving around 1,300 seniors, offering a range of services including primary and specialty medical care, dental services, rehabilitation therapies, and social activities [4]. Tampa General Hospital Overview - Tampa General Hospital is recognized as the 1 hospital in the Tampa Bay region for the 10th consecutive year and is noted for its excellence in geriatrics [3]. - The hospital is a not-for-profit academic health system with 1,529 beds and is the only center for Level 1 trauma and comprehensive burn care in the region [7]. - In fiscal year 2023, Tampa General provided a net community benefit of approximately $301.8 million, supporting underinsured patients and community health organizations [8].

New EHR to increase staff efficiency and enhance care coordination AUSTIN, Texas, Aug. 12, 2025 /PRNewswire/ -- Cambridge Memorial Hospital (CMH) has selected Oracle Health's Foundation electronic health record (EHR) to support improved clinical decision-making, enhance the patient experience, and enable more coordinated care across its teams. As part of its ongoing digital transformation strategy, CMH will adopt Oracle Health's EHR to create a modern infrastructure that drives staff efficiency, fosters inn ...

"白天没时间，小病一拖再拖。"针对白天忙于工作无暇就医的患者，在省卫生健康委员会的推动 下，我省多家医疗机构纷纷开设夜门诊。截至目前，全省已有99家三级医院提供夜诊服务，覆盖儿科、 康复科、针灸推拿科、骨科、耳鼻喉科、皮肤科等多个专科，累计接诊量达860.9万人次。 中医特色夜门诊吸引"上班族" 晚上6点，常州市中医院门诊二楼颈腰痛诊疗中心、传统疗法综合治疗中心热闹非凡。"大夫，我最 近睡眠不好，想来调理一下。"白领王先生表示，白天工作特别忙，想看病得专门请假。该院开设的"中 医夜门诊"，让他有了两全其美的解决办法："下了班就赶过来，还不用排长队，太方便了。" 泰兴市中医院今年6月推出"颈腰痛"夜门诊服务，针对颈肩腰腿痛等常见病症，开展针灸、推拿、 穴位埋线等多项传统中医特色疗法，尤其适合长期伏案工作、颈腰椎不适的职场人士和学习压力较大的 学生群体。 夜幕下，记者在泰兴市中医院"颈腰痛"夜门诊诊区看到，前来就诊的市民络绎不绝。从事设计工作 的林先生告诉记者，他长期对着电脑工作，几年前患上了颈椎病，"以前疼了就忍忍，现在下班顺便来 做个针灸，晚上睡觉踏实多了。" 为方便患者能在8小时外享受优质医疗服务，无锡市中 ...

And finally, there is good news tonight about someone who got really creative with casual Fridays to bring joy and comfort where it is needed the most. Here's George. Three.At Galisano Children's Hospital in South Florida, Terry Aldrid isn't just a worker, she's a character. That's luau coming up. No, really, she is.That's her dressed as Sully from Monsters, Inc. manning the service desk. Thank you for calling. Answering calls.Hello. And checking in young patients ahead of surgery. For a lot of people, they ...

Financial Data and Key Metrics Changes - In Q2 2025, revenue increased by 11.9% to $1.65 billion, driven by adjusted admissions growth of 1.6% and net patient service revenue per adjusted admission growth of 10.2% [21] - Adjusted EBITDA grew 39% year over year to $170 million, with an adjusted EBITDA margin increase of 200 basis points to 10.3% [21] - Year-to-date adjusted EBITDA grew 23%, with margins expanding by 100 basis points compared to the prior year period [21] - Operating cash flow for Q2 was $117 million, with total cash at $541 million and total debt outstanding at $1.1 billion, resulting in a net leverage ratio of 2.7 times, improved from 3.0 times at the end of Q1 [22] Business Line Data and Key Metrics Changes - Admissions growth was strong at 6.6% year over year, with inpatient surgeries increasing by 9.2% in Q2, while outpatient surgeries declined by 3.8% [21][22] - Exchange admissions grew approximately 35% year over year, while commercial admissions (excluding exchange plans) and Medicaid admissions both increased by approximately 8% [21] Market Data and Key Metrics Changes - The company operates in eight growing mid-sized markets, which continue to drive demand due to an aging and increasingly complex patient population [5] - The company has seen nearly 40% growth in exchange admissions in 2025, although reimbursement rates for this population are less favorable compared to commercial rates [14] Company Strategy and Development Direction - The company is focused on expanding its outpatient services, with plans to open five urgent care centers and two imaging centers in 2025, complementing the 18 urgent care centers acquired earlier this year [9] - The IMPACT program aims to improve margins, performance, agility, and care transformation, with a focus on cost efficiency and operational agility [17][24] - The company is well-positioned to pursue strategic growth opportunities, particularly through joint ventures with academic partners in the acute care space [23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining strong performance despite ongoing industry-wide payer denial headwinds, with a focus on operational workflow initiatives and strategic growth priorities [18][27] - The regulatory environment is being closely monitored, particularly regarding the Big Beautiful Bill (OBBA) and its potential impact on Medicaid funding [12][13] - Management anticipates a de minimis impact to earnings in 2026 and 2027, with the majority of financial effects occurring between 2028 and 2035 [14] Other Important Information - The company has reaffirmed its full-year 2025 financial guidance, indicating confidence in meeting its targets [18][25] - The company is now S-3 eligible following its one-year anniversary as a public company, allowing for potential capital raising opportunities in the future [25][26] Q&A Session Summary Question: Can you provide an update on managed care and the impact of terminated exchange contracts? - Management noted significant growth in exchange volume but mentioned that some plans were yielding poor rates, leading to the termination of one large plan [34] - Denial rates have increased, but the company remains focused on optimizing payer contracts to ensure appropriate compensation [35][36] Question: What is the outlook for the ambulatory strategy and its volume benefits? - The company is focused on growing the number of unique patients served in each market, with a current average of close to ten ambulatory access points per hospital [40] - Approximately 45% of patients from newly acquired urgent care centers were new to the company, indicating strong potential for follow-up care and additional services [42] Question: How is inpatient surgical growth performing and what categories are driving this? - Inpatient surgeries have been strong, particularly in orthopedics and cardiology, aligning with the company's service line rationalization strategy [47] Question: What are the expectations for capital expenditures moving forward? - The company expects capital expenditures to trend at or above 4% of revenues, with a focus on investing in ambulatory build-out [93] Question: How does the company view the impact of the recent Medicare OPPS and ASC rule changes? - Management believes that the shift from inpatient to outpatient care has been ongoing and does not expect a significant influx of patients moving from inpatient to outpatient settings due to clinical acuity needs [99] Question: Can you provide details on the Medicaid supplemental programs and their future? - Management expressed confidence that approved programs in New Mexico and Oklahoma will qualify for grandfathering provisions under the OBBA, ensuring their durability [90][91]

Financial Performance - Total revenue for 2Q25 was $1645 million, an increase of 11.9% year-over-year[14, 18] - Adjusted EBITDA for 2Q25 was $170 million, a 38.9% increase year-over-year[14, 18] - Adjusted EBITDA margin for 2Q25 was 10.3%, a 200 bps expansion[14, 18] - For the first half of 2025, total revenue reached $3143 million, reflecting an 8.0% year-over-year growth[14] - Adjusted EBITDA for YTD 2Q25 was $268 million, up 22.9% year-over-year[14] - Adjusted EBITDA margin for YTD 2Q25 was 8.5%, a 100 bps increase[14] Operating Metrics - Admissions increased by 6.6% year-over-year in 2Q25[14, 26] - Adjusted admissions increased by 1.6% year-over-year in 2Q25 and 2.2% year-to-date[14, 16, 22] - Net patient service revenue per adjusted admission increased by 10.2% year-over-year[14, 25, 27] Payor Mix - Managed Care accounted for 44.7% of Net Patient Service Revenue in 2Q25, an increase of 80 bps year-over-year[29, 30] - Medicare accounted for 40.0% of Net Patient Service Revenue in 2Q25[29, 32] - Medicaid accounted for 10.7% of Net Patient Service Revenue in 2Q25[29, 33]

Rural Healthcare Crisis - Rural healthcare faces a crisis due to potential cuts and closures [1][2] - Texas children, especially those outside major cities, risk losing healthcare access due to Medicaid cuts affecting 30-40% of children [1] - Many Texas counties lack hospitals equipped for childbirth, posing risks for pregnant individuals in emergencies [3] Impact of Policy - A policy is projected to shut down over 300 rural hospitals nationwide [2] - East Texas families may need to travel 45 minutes to an hour to reach a hospital [2] - Rural hospitals struggle to remain open, facing challenges exacerbated by government actions [3] Government Responsibility - The government's role is to provide services to its citizens, not to generate profit [4] - The government is failing to provide services to working-class people [4] - Resources meant for public services are being redirected to wealthy individuals [4]

Group 1 - The core viewpoint of the news is the recognition of Binzhou Medical College Affiliated Hospital as one of the "Top 100 International Science and Technology Cooperation Institutions" by the China International Science and Technology Cooperation Association, highlighting its significant contributions to international scientific collaboration [2] - The hospital has established close ties with institutions in countries such as the United States, Australia, Singapore, and the United Kingdom, focusing on personnel exchanges and academic collaborations [2] - Over the years, the hospital has successfully recruited a lifetime professor from a global Top 200 university and has engaged in academic exchanges with renowned institutions like Harvard Medical School and the University Medical Center Groningen [2] Group 2 - The recognition serves as both an acknowledgment of the hospital's long-term commitment to international scientific cooperation and a result of its diligent efforts in this field [3] - The hospital plans to leverage this recognition to enhance its international talent exchange and cooperation, establishing regular collaborative mechanisms with high-level overseas universities and research institutions [3] - The focus will be on enriching the forms of overseas talent exchange and cooperation, which is expected to empower the hospital's high-quality development [3]

Financial Data and Key Metrics Changes - In Q2 2025, total revenue declined by 3.6%, with EBITDA and net profit decreasing by 1.6% and 3.8% respectively [27][28][33] - The EBITDA margin for Q2 was 41.6%, while the net profit margin was 30.4% [27][33] - For the first half of 2025, total revenue was down 4.6%, with a 5.3% decline in hospital operation revenue [30][33] Business Line Data and Key Metrics Changes - Revenue from non-Thai patients decreased by 6.6%, while Thai patient revenue slightly declined by 0.2% [27][30] - The outpatient service revenue contribution increased to 51% in the first half of 2025, up from 49% in the same period last year [31] - The government third-party contribution dropped to 14% from 18% in the first half of last year due to lower Middle East revenue [31] Market Data and Key Metrics Changes - Middle Eastern business showed strong growth, with Qatar up 18%, UAE up 46%, Oman up 28%, and Saudi Arabia up 54% [6][7] - The company experienced a decline in revenue from the Indo-China segment, particularly from Cambodia, which was offset by growth in Myanmar and Bangladesh [29][30] - The Chinese market saw a significant reduction in patient arrivals, down by over 30% to 40% year over year due to safety concerns [65][66] Company Strategy and Development Direction - The company is focusing on expanding its cancer care services and enhancing patient experience through new facilities and advanced technologies [88][92] - There is an emphasis on strengthening relationships with key stakeholders and third-party payers to drive growth [84] - The company aims to improve its market position by addressing governance issues and enhancing service quality for Kuwaiti patients [42][56] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for Q3 2025, expecting stronger performance compared to the first half of the year [18][26] - The company is cautiously optimistic about the return of Kuwaiti patients and the resolution of past payment issues [46][56] - Management highlighted the importance of addressing safety concerns to regain Chinese patient trust and increase medical tourism [66][70] Other Important Information - The company achieved recognition as one of the best specialized hospitals in Thailand across multiple specialties [77][78] - A successful disease screening campaign generated nearly 96 million baht in revenue within two months [80] - The company is actively investing excess cash into financial assets to capture higher interest income [34][35] Q&A Session Summary Question: What are the expectations for the Kuwaiti market? - Management indicated that discussions with Kuwaiti officials are ongoing, and there is cautious optimism about future collaborations and patient flow [46][56] Question: How is the company addressing the decline in Chinese patient arrivals? - The company is expanding its presence in China and engaging in targeted outreach to rebuild trust and increase referrals [66][70] Question: What are the key initiatives for cancer care expansion? - The company is focusing on comprehensive cancer care, integrating advanced technologies, and enhancing patient experience through new facilities [88][92]

Financial Data and Key Metrics Changes - The total revenue for Q2 2025 was 6,000 million baht, representing a decline of 3.6% year-over-year [26][27] - EBITDA margin reached a record high of 41.6%, while net profit margin was 30.4%, slightly up from 30.5% in the previous year [9][33] - EPS was reported at 40 baht, with a dividend payout ratio of 44% for the interim dividend, up from 41% the previous year [13] Business Line Data and Key Metrics Changes - Revenue from non-Thai patients decreased by 6.6%, while Thai patient revenue slightly declined by 0.2% [26][28] - The outpatient service revenue contribution increased to 51% from 49% in the first half of the previous year, while inpatient service revenue remained at 50% [31] - The MDA segment saw a significant decline of 12.4%, primarily from Qatar, Kuwait, and Oman, while the Indo-China segment increased by 0.4% [29][30] Market Data and Key Metrics Changes - Middle Eastern business showed strong growth, with Qatar up 18%, UAE up 46%, Oman up 28%, and Saudi Arabia up 54% [5][6] - The company experienced a decline in revenue from Chinese patients, with a drop of over 30% to 40% year-over-year due to safety concerns [65] - The Cambodian market is expected to stabilize, which could improve OPD footfalls and admissions in the future [66] Company Strategy and Development Direction - The company is focusing on expanding its cancer care services, recognizing the growing global cancer crisis and the need for comprehensive care [89][90] - Plans for a new cancer care facility are underway, aimed at enhancing patient experience and integrating advanced technologies [95] - The company is actively negotiating with the Kuwaiti government regarding patient payments and potential future collaborations [39][46] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for Q3 2025, expecting stronger performance compared to the first half of the year [16][25] - The company is cautiously optimistic about the return of Kuwaiti patients, emphasizing the importance of quality care and governance [46][60] - The geopolitical situation in Cambodia and China is impacting patient flow, but management is hopeful for recovery in these markets [66][70] Other Important Information - The company received recognition from Newsweek as one of the best specialized hospitals in Thailand, ranking number one in six out of nine specialties [79] - A successful disease screening campaign generated nearly 96 million baht in revenue within two months [82] - The company upgraded its robotic surgery capabilities, expanding to more specialties and training additional surgeons [84] Q&A Session Summary Question: What is the outlook for the Kuwaiti market? - Management indicated that discussions with Kuwaiti officials are ongoing, and there is cautious optimism about future patient flow and payments [39][46] Question: How is the company addressing the decline in Chinese patients? - The company is expanding its presence in China and engaging in online outreach to improve connections with potential patients [67][68] Question: What are the expectations for the second half of 2025? - Management expects stronger performance in the second half compared to the first half, driven by recovery in key markets [16][25]